TFEB dysregulation has been reported in several neurodegenerative diseases, mainly by reduced nuclear localization, such as in the postmortem brains of Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis patients [33,34,35]. Here, TFEB is linked to Alzheimer disease.